Skip to content

Mechanisms Underlying Amylin Enhanced Regulatory T Cell Function

Mechanisms Underlying Amylin Enhanced Regulatory T Cell Function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-14005310
Enrollment
Unknown
Registered
2014-10-08
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Three groups:N/A

Sponsors

Affiliated Hospital of Guilin Medical Univercity
Lead Sponsor

Eligibility

Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed T1D, T2D, and healthy controls.

Exclusion criteria

Exclusion criteria: (1) Using varieties of drugs to control blood glucose, blood pressure, blood lipid and inflammation; (2) Subjects deprived of personal safety and presence of any of the chronic diseases including stroke,myocardial infarction, other heart, liver, renal and respiratory dysfunction were excluded as progression of these in any stage mayhinder our study; (3) Pregnant subjects and subjects with malignancy; (4) Does not need assistance from the medical staffs to complete the survey.

Design outcomes

Primary

MeasureTime frame
Hight;Weight;waist circumference;hip circumference;blood pressure;ECG;body fat;Urinary albumin /creatinine ratio;Glucose tolerance test;serum lipid;ALT;AST;creatinine;BUN;

Countries

China

Contacts

Public ContactZhao Hailu
zhaohailu9@126.com+86 15295890899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026